Population
Recombinant human calreticulin expressed in E. coli as a fusion protein with maltose-binding protein and its…
Comparison
N-terminal deletions and domain isolations of… vs Full-length calreticulin or MBP alone
Design
Preclinical
Authors
Loading...
Localizes rubella activities to calreticulin N-terminal domains; leaves open targeted antiviral strategies pending human validation.
Both the rubella virus RNA-binding and autophosphorylation activities of human calreticulin are localized to its N-terminal domain.
Atreya et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: